At Revitope, with our team of creative and highly engaged scientists and industry veterans, we have engineered next-generation therapeutic T cell engagers that are active only when they bind two ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Programmed cell death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies ...

Weill Cornell Medicine researchers have discovered a way ovarian tumors cripple immune cells: by tampering with their ability ...

Programmed Cell Death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies called checkpoint ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

"Researchers have focused on a protein called fatty acid-binding protein 5, or FABP5, which facilitates lipid uptake, but its exact location within the T cell remained unclear," said Dr. Sung-Min ...

overexpressed in normal cells, such as red blood cells and cancer cells. Sino Biological has used the Beacon ® single B cell platform to screen various CD47 antibodies that bind to protein and ...

Research shows coffee can make you healthier, smarter, and more productive. (And if you don't like coffee, sometimes other ...

CD19-targeted therapies like CAR-T and T-cell engagers (TCEs) are used for B-cell malignancies, with early success in autoimmune diseases like SLE. However, TCEs face challenges due to ...

Patients with Huntington’s disease have a genetic mutation that triggers proteins to misfold and clump together in the brain.